The odd couple: A fresh look at autoimmunity and immunodeficiency

Journal of Autoimmunity

Volumn 35, Issue 3, 2010, Pages 199-205

  Mackay, Ian R ^a   Leskovsek, Natasha V ^b   Rose, Noel R ^c,d  

^a MONASH UNIVERSITY   (Australia)

^b Cooley LLP ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Autoimmunity; Complement deficits; Immunogenetics; Monogenic disorders; Primary immunodeficiency; Regulatory T cells

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; B CELL ACTIVATING FACTOR; CD40 LIGAND; FAS ANTIGEN; FAS LIGAND; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; RAG1 PROTEIN; RAG2 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; AUTOIMMUNE POLYENDOCRINOPATHY; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; B LYMPHOCYTE; CELL THERAPY; CHROMOSOME 22Q; CHROMOSOME DELETION; COMMON VARIABLE IMMUNODEFICIENCY; DIGEORGE SYNDROME; EPIGENETICS; HELLP SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOGLOBULIN A DEFICIENCY; INNATE IMMUNITY; IPEX SYNDROME; MOLECULAR GENETICS; NONHUMAN; OMENN SYNDROME; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RETINA MACULA AGE RELATED DEGENERATION; SOMATIC MUTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THYMOMA; WISKOTT ALDRICH SYNDROME; X LINKED AGAMMAGLOBULINEMIA;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; BIOMEDICAL RESEARCH; EPIGENESIS, GENETIC; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTERDISCIPLINARY COMMUNICATION; SOCIETIES, SCIENTIFIC; T-LYMPHOCYTES;

EID: 77957771966     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.06.008     Document Type: Article

References (49)

1. Rose N.R., Leskovsek N. Scleroderma: immunopathogenesis and treatment. Immunol Today 1998, 19(11):499-501.
2. Mackay I.R., Rose N.R. Autoimmunity and lymphoma: tribulations of B cells. Nat Immunol 2001, 2(9):793-795.
3. Mackay I.R., Leskovsek N.V., Rose N.R. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 2008, 30(1-2):5-11.
4. International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies, Notarangelo L.D., Fischer A., Geha R.S., Casanova J.L., Chapel H., Conley M.E., et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009, 124(6):1161-1178.
5. Guo P., Hirano M., Herrin B.R., Li J., Yu C., Sadlonova A., et al. Dual nature of the adaptive immune system in lampreys. Nature 2009, 459(7248):796-801.
6. Rieux-Laucat F., Le Deist F., Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ 2003, 10(1):124-133.
7. Hsu A.P., Fleisher T.A., Niemela J.E. Mutation analysis in primary immunodeficiency diseases: case studies. Curr Opin Allergy Clin Immunol 2009, 9(6):517-524.
8. Holzelova E., Vonarbourg C., Stolzenberg M.C., Arkwright P.D., Selz F., Prieur A.M., et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med 2004, 351(14):1409-1418.
9. Heino M., Peterson P., Kudoh J., Shimizu N., Antonarakis S.E., Scott H.S., et al. APECED mutations in the autoimmune regulator (AIRE) gene. Hum Mutat 2001, 18(3):205-211.
10. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002, 298(5597):1395-1401.
11. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27(1):20-21.
12. Ochs H.D., Oukka M., Torgerson T.R. TH17 cells and regulatory T cells in primary immunodeficiency diseases. J Allergy Clin Immunol 2009, 123(5):977-983.
13. Villa A., Santagata S., Bozzi F., Giliani S., Frattini A., Imberti L., et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 1998, 93(5):885-896.
14. Pessach I.M., Notarangelo L.D. X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity. J Autoimmun 2009, 33(1):17-24.
15. Shearer W.T., Rosenblatt H.M., Gelman R.S., Oyomopito R., Plaeger S., Stiehm E.R., et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trial Group P1009 study. J Allergy Clin Immunol 2003, 112(5):973-980.
16. Markert M.L., Devlin B.H., Chinn I.K., McCarthy E.A. Thymus transplantation in complete DiGeorge anomaly. Immunol Res 2009, 44(1-3):61-70.
17. Schurman S.H., Candotti F. Autoimmunity in Wiscott-Aldridge syndrome. Curr Opin Rheumatol 2003, 15(4):446-453.
18. Coutinho A., Carneiro-Sampaio M. Primary immunodeficiencies unravel critical aspects of the pathophysiology of autoimmunity and of the genetics of autoimmune disease. J Clin Immunol 2008, 28(Suppl 1):S4-S10.
19. Shevach E.M. Mechanisms of FOXP3+ T regulatory cell-mediated suppression. Immunity 2009, 30(5):636-645.
20. Datta S., Sarvetnick N. Lymphocyte proliferation in immune-mediated diseases. Trends Immunol 2009, 30(9):430-438.
21. Nashi E., Wang Y., Diamond B. The role of B cells in lupus pathogenesis. Int J Biochem Cell Biol 2010, 42(4):543-550.
22. Li Y., Begovich A.B. Unraveling the genetics of complex diseases: susceptibility genes for rheumatoid arthritis and psoriasis. Sem Immunol 2009, 21:318-327.
23. Pescovitz M.D., Greenbaum C.J., Krause-Steinrauf H., Becker D.J., Gitelman S.E., Goland R., et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. New Engl J Med 2009, 361(22):2143-2152.
24. Leandro M.J., de la Torre I. Translational mini-review series on B-cell directed therapies: the pathogenic role of B cells in autoantibody-associated autoimmune diseases - lessons from B cell depletion therapy. Clin Exp Immunol 2009, 157(2):191-197.
25. Duddy M.E., Alter A., Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation. J Immunol 2004, 172:3422-3427.
26. Wallace D.J., Stohl W., Furie R.A., Lisse J.R., McKay J.D., Merrill J.T., et al. A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. Arthritis Rheum 2009, 61(9):1168-1178.
27. Herve M., Isnardi I., Ng Y.S., Bussel J.B., Ochs H.D., Cunningham-Rundles C., et al. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med 2007, 204(7):1583-1593.
28. Conley M.E., Dobbs A.K., Farmer D.M., Kilic S., Paris K., Grigoriadou S., et al. Campana D Primary B cell immunodeficiencies: Comparisons and contrasts. Ann Rev Immunol 2009, 27:199-227.
29. Bussone G., Mouthon L. Autoimmune manifestations in primary immunodeficiencies. Autoimmun Rev 2009, 8:332-336.
30. Brandt D., Gershwin M.E. Common variable immune deficiency and autoimmunity. Autoimmun Rev 2006, 5:465-470.
31. Cunningham-Rundles C. Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol 2008, 28(Suppl 1):S42-S45.
32. Jacob C.M., Pastorino A.C., Fahl K., Carneiro-Sampaio M., Moneiro R.C. Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper. J Clin Immunol 2008, 28(Suppl 1):S56-S61.
33. Blom A.M. Complement: deficiency diseases. Encyclopedia of Life sciences January 2010, 1-8. John Wiley & Sons, Ltd.
34. Kemper C., Atkinson J.P., Hourcade D.E. Properdin: emerging roles of a pattern-recognition molecule. Annu Rev Immunol 2010, 28:131-155.
35. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
36. Masters S.L., Simon A., Aksentijevich I., Kastner D.L. Horror autoinflammmaticus: the molecular pathophysiology of autoinflammatory disease. Ann Rev Immunol 2009, 27:621-688.
37. Kivity S., Agmon-Levin N., Blank M., Shoenfeld Y. Infections and autoimmunity - friends or foes?. Trends Immunol 2009, 30(8):409-414.
38. Ansari A.A. Navigating the passage between Charybdis and Scylla: recognizing the achievements of Noel Rose. J Autoimmun 2009, 33:165-169.
39. Whittingham S., Rowley M.J., Gershwin M.E. A tribute to an outstanding immunologist - Ian Reay Mackay. J Autoimmun 2008, 31:197-200.
40. Mackay I.R. Clustering and commonalities among autoimmune diseases. J Autoimmun 2009, 33:170-177.
41. Burek C.L., Talor M.V. Environmental triggers of autoimmune thyroiditis. J Autoimmun 2009, 33:183-189.
42. Cooper G.S., Bynum M.L.K., Somers E.C. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009, 33:197-207.
43. Invernizzi P., Gershwin M.E. The genetics of human autoimmune disease. J Autoimmun 2009, 33:290-299.
44. Leuschner F., Katus H.A., Kaya Z. Autoimmune myocarditis: past, present and future. J Autoimmun 2009, 33:282-289.
45. Frazer I.H. Autoimmunity and persistent viral infection: two sides of the same coin?. J Autoimmun 2008, 31:216-218.
46. Vital E.M., Emery P. The development of targeted therapies in rheumatoid arthritis. J Autoimmun 2008, 31:219-227.
47. Lleo A., Selmi C., Invernizzi P., Podda M., Gershwin M.E. The consequences of apoptosis in autoimmunity. J Autoimmun 2008, 31:257-262.
48. Dardalhon V., Korn T., Kuchroo V.K., Anderson A.C. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008, 31:252-256.
49. Payne N., Siatskas C., Bernard C.A. The promise of stem cell and regenerative therapies for multiple sclerosis. J Autoimmun 2008, 31:288-294.